Skip to main content

Q Global Advisors, LLC

SEC CIK
0001469589
Latest filing
Aug 14, 2026

The latest 13F from Q Global Advisors, LLC covers Q2 2026 (filed Aug 14, 2026): 47 long positions worth $147.5M. The top 10 holdings make up 90.3% of the portfolio, and the largest is Ascendis Pharma A/S (ASND) at 18.1%. Livermore has 24 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
3
Est. +$39.0M
Added
5
Est. +$24.4M
Reduced
3
Est. −$17.2M
Sold out
4
Est. −$21.7M

Top 5 holdings

Share of this quarter's portfolio value

  1. ASNDAscendis Pharma A/S
    18.1%$26.7MHistory
  2. MSFTMicrosoft Corp
    15.1%$22.2MHistory
  3. BXBlackstone Inc.
    8.8%$12.9MHistory
  4. GOOGAlphabet Inc.
    8.6%$12.6MHistory
  5. AMZNAmazon Com Inc
    8.4%$12.4MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. MSFTMicrosoft Corp
    +$22.2MNewHistory
  2. GOOGAlphabet Inc.
    +$12.6MNewHistory
  3. AMZNAmazon Com Inc
    +$8.73MAddedHistory
  4. BXBlackstone Inc.
    +$5.77MAddedHistory
  5. KKRKKR & Co. Inc.
    +$4.69MAddedHistory

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. MSFTMicrosoft Corp
    +15.08 pp0.0% → 15.1%History
  2. GOOGAlphabet Inc.
    +8.58 pp0.0% → 8.6%History
  3. AMZNAmazon Com Inc
    +5.32 pp3.1% → 8.4%History
  4. Invesco QQQ Trust Series I46090E103
    +2.80 pp0.0% → 2.8%
  5. BXBlackstone Inc.
    +2.03 pp6.7% → 8.8%History

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. ENVAEnova International, Inc.
    −$14.2MReducedHistory
  2. SPYSPDR S&P 500 ETF Trust
    −$13.0MSold outHistory
  3. PGYPagaya Technologies Ltd.
    −$6.26MSold outHistory
  4. NCLHNorwegian Cruise Line Holdings Ltd.
    −$2.28MSold outHistory
  5. HQWWWHorizon Quantum Holdings Ltd.
    −$2.21MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. SPYSPDR S&P 500 ETF Trust
    −12.51 pp12.5% → 0.0%History
  2. ENVAEnova International, Inc.
    −6.60 pp12.2% → 5.6%History
  3. PGYPagaya Technologies Ltd.
    −6.02 pp6.0% → 0.0%History
  4. CCLCarnival Corp Ltd.
    −2.69 pp10.0% → 7.3%History
  5. NCLHNorwegian Cruise Line Holdings Ltd.
    −2.19 pp2.2% → 0.0%History

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$147.5M
+$43.5M (+41.8%) vs. prior quarter
Positions
47
−1 vs. prior quarter
Top 10 concentration
90.3%
Top 10 as share of value
Turnover
30.9%
Q2 2026, one quarter
Average holding period
2.8 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $387.2M (Q4 2021)

Q1 2021: $262.5MQ2 2021: $120.5MQ3 2021: $99.7MQ4 2021: $387.2MQ1 2022: $163.3MQ2 2022: $128.9MQ3 2022: $145.3MQ4 2022: $206.6MQ1 2023: $142.9MQ2 2023: $138.7MQ3 2023: $155.5MQ4 2023: $132.0MQ1 2024: $263.7MQ2 2024: $141.0MQ3 2024: $113.7MQ4 2024: $97.0MQ1 2025: $123.0MQ2 2025: $118.9MQ3 2025: $63.7MQ4 2025: $101.6MQ1 2026: $104.0MQ2 2026: $147.5M
Q1 2021Q2 2026
13F filings of Q Global Advisors, LLC by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 202647$147.5MASNDMSFTBXvs. Q1 2026SEC
Q1 2026May 15, 202648$104.0MASNDSPYENVAvs. Q4 2025SEC
Q4 2025Feb 17, 202648$101.6MASNDENVASPYvs. Q3 2025SEC
Q3 2025Nov 13, 202542$63.7MASNDENVATDGvs. Q2 2025SEC
Q2 2025Aug 14, 202550$118.9MASNDiShares Russell 2000 ETFTDGvs. Q1 2025SEC
Q1 2025May 14, 202551$123.0MiShares Russell 2000 ETFASNDSPYvs. Q4 2024SEC
Q4 2024Feb 24, 2025Amended51$97.0MASNDMODVPRKSvs. Q3 2024SECSEC
Q3 2024Nov 12, 202468$113.7MASNDPRKSState Street SPDR S&P Biotech ETFvs. Q2 2024SEC
Q2 2024Aug 14, 202493$141.0MASNDPRKSState Street SPDR S&P Biotech ETFvs. Q1 2024SEC
Q1 2024May 15, 2024112$263.7MSPYiShares Russell 2000 ETFASNDvs. Q4 2023SEC
Q4 2023Feb 13, 2024117$132.0MASNDPRKSState Street SPDR S&P Biotech ETFvs. Q3 2023SEC
Q3 2023Nov 14, 2023154$155.5MPRKSASNDState Street SPDR S&P Biotech ETFvs. Q2 2023SEC
Q2 2023Aug 14, 2023166$138.7MPRKSState Street SPDR S&P Biotech ETFHRIvs. Q1 2023SEC
Q1 2023May 15, 2023184$142.9MPRKSState Street SPDR S&P Biotech ETFPLAYvs. Q4 2022SEC
Q4 2022Feb 14, 2023219$206.6MSPYPRKSPLAYvs. Q3 2022SEC
Q3 2022Nov 14, 2022270$145.3MPRKSPLAYASNDvs. Q2 2022SEC
Q2 2022Aug 15, 2022267$128.9MPRKSPLAYState Street SPDR S&P Biotech ETFvs. Q1 2022SEC
Q1 2022May 16, 2022312$163.3MPRKSState Street SPDR S&P Biotech ETFiShares Russell 2000 ETFvs. Q4 2021SEC
Q4 2021Feb 15, 2022358$387.2MPRKSSPYInvesco QQQ Trust Series Ivs. Q3 2021SEC
Q3 2021Nov 16, 2021145$99.7MInvesco QQQ Trust Series IBBWIASNDvs. Q2 2021SEC
Q2 2021Aug 17, 2021141$120.5MLADRCLDTBBWIvs. Q1 2021SEC
Q1 2021May 17, 2021127$262.5MSPYAdamas Trust, Inc.OXLC–SEC